BG62912B1 - Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол - Google Patents

Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол Download PDF

Info

Publication number: BG62912B1
Authority: BG; Bulgaria
Prior art keywords: weight; composition according; composition; salt; mupirocin
Prior art date: 1993-10-22

Application number

BG100501A

Other languages

Bulgarian (bg)

English (en)

Other versions

BG100501A (bg

Inventor

Harvey L. Zimmerman

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-22

Filing date

1996-04-12

Publication date

2000-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303736&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG62912(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-10-22 Priority claimed from GB939321876A external-priority patent/GB9321876D0/en

1993-10-29 Priority claimed from GB939322288A external-priority patent/GB9322288D0/en

1996-04-12 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

1996-12-31 Publication of BG100501A publication Critical patent/BG100501A/bg

2000-11-30 Publication of BG62912B1 publication Critical patent/BG62912B1/bg

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BG100501A 1993-10-22 1996-04-12 Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол BG62912B1 (bg)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB939321876A GB9321876D0 (en)	1993-10-22	1993-10-22	Novel composition
GB939322288A GB9322288D0 (en)	1993-10-29	1993-10-29	Novel composition
PCT/US1994/012026 WO1995010999A1 (en)	1993-10-22	1994-10-20	Novel composition

Publications (2)

Publication Number	Publication Date
BG100501A BG100501A (bg)	1996-12-31
BG62912B1 true BG62912B1 (bg)	2000-11-30

Family

ID=26303736

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG100501A BG62912B1 (bg)	1993-10-22	1996-04-12	Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол

Country Status (28)

Country	Link
US (1)	US6025389A (fi)
EP (1)	EP0727979B1 (fi)
JP (1)	JPH09506865A (fi)
KR (1)	KR100374462B1 (fi)
CN (1)	CN1102410C (fi)
AP (1)	AP608A (fi)
AT (1)	ATE202467T1 (fi)
AU (1)	AU692486B2 (fi)
BG (1)	BG62912B1 (fi)
BR (1)	BR9407840A (fi)
CA (1)	CA2174658C (fi)
CZ (1)	CZ292223B6 (fi)
DE (1)	DE69427589T2 (fi)
DK (1)	DK0727979T3 (fi)
ES (1)	ES2157996T3 (fi)
FI (1)	FI116931B (fi)
GR (1)	GR3036591T3 (fi)
HK (1)	HK1012284A1 (fi)
HU (1)	HU221853B1 (fi)
NO (1)	NO313446B1 (fi)
NZ (1)	NZ275282A (fi)
OA (1)	OA10361A (fi)
PL (1)	PL177592B1 (fi)
PT (1)	PT727979E (fi)
RO (1)	RO112987B1 (fi)
SK (1)	SK280222B6 (fi)
UA (1)	UA39896C2 (fi)
WO (1)	WO1995010999A1 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO4910145A1 (es) *	1996-10-01	2000-04-24	Smithkline Beecham Corp	Uso
BR9711843A (pt) *	1996-10-01	2001-07-31	Smithkline Beecham Corp	Uso de mupirocina para a fabricação de um medicamento para o tratamento de infecções bacterianas associadas com colonização da nasofaringe por organimos patogênicos
CA2303443A1 (en) *	1997-09-11	1999-03-18	Anthony Guy Hatton	Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) *	1998-02-02	2001-08-26	Agis Ind 1983 Ltd	Pharmaceutical compositions containing mupirocin
GB9808470D0 (en)	1998-04-22	1998-06-17	Smithkline Beecham Plc	Novel process and apparatus
IL137363A (en) *	2000-07-18	2005-12-18	Agis Ind 1983 Ltd	Pharmaceutical compositions containing mupirocin
IL150907A (en) *	2002-07-25	2007-07-04	Stephan Cherkez	Process for the preparation of stable amorphous calcium pseudomonate
AU2004258821A1 (en) *	2003-05-01	2005-02-03	Replidyne, Inc.	Antibacterial methods and compositions
US20050123576A1 (en) *	2003-12-03	2005-06-09	Ilana Lavon	Mupirocin compositions for topical use, an improved process of making same and methods of using same
WO2008007182A2 (en) *	2006-07-07	2008-01-17	Glenmark Pharmaceuticals Limited	Topical pharmaceutical compositions of mupirocin or pharmaceutically acceptable salts or esters thereof
WO2011121345A1 (en)	2010-03-30	2011-10-06	Helperby Therapeutics Limited	Novel combination and use
DK2600869T3 (da)	2010-08-05	2020-11-16	Helperby Therapeutics Ltd	Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin
GB201013207D0 (en)	2010-08-05	2010-09-22	Helperby Therapeutics Ltd	Novel combination
GB201015079D0 (en)	2010-09-10	2010-10-27	Helperby Therapeutics Ltd	Novel use
JP2013538868A (ja)	2010-10-08	2013-10-17	ヘルパービーセラピューティクスリミテッド	新規な組成物
EP2704704B1 (en)	2011-05-03	2018-09-26	DuPont Nutrition Biosciences ApS	Probiotic bacteria for the topical treatment of skin disorders
GB201107755D0 (en)	2011-05-10	2011-06-22	Helperby Therapeutics Ltd	Novel compounds
CN102335122B (zh) *	2011-06-21	2013-04-17	北京协和药厂	一种莫匹罗星软膏及其制备方法
DE102012215511A1 (de)	2012-08-31	2014-06-12	Schülke & Mayr GmbH	Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
GB201305277D0 (en)	2013-03-22	2013-05-01	Helperby Therapeutics Ltd	Novel combination and use
GB201307989D0 (en)	2013-05-02	2013-06-12	Helperby Therapeutics Ltd	Novel combinations and use
AU2014377875B2 (en) *	2013-12-17	2018-07-19	Dr. Reddy's Laboratories Sa	Pediculicidal composition
GB201401617D0 (en)	2014-01-30	2014-03-19	Helperby Therapeutics Ltd	Novel combination and use
WO2016097754A1 (en)	2014-12-18	2016-06-23	Helperby Therapeutics Limited	Novel combination and use
WO2016133471A1 (en)	2015-02-20	2016-08-25	Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş.	A topical composition comprising mupirocin and dexpanthenol
GB201518969D0 (en)	2015-10-27	2015-12-09	Helperby Therapeutics Ltd	Triple combination
JP2019513769A (ja)	2016-04-19	2019-05-30	ザユナイテッドステイツオブアメリカ，アズレプリゼンテッドバイザセクレタリー，デパートメントオブヘルスアンドヒューマンサービシーズ	アトピー性皮膚炎を処置するためのグラム陰性種の使用
US10293005B2 (en)	2016-04-19	2019-05-21	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Use of gram negative species to treat atopic dermatitis
GB201610869D0 (en)	2016-06-22	2016-08-03	Helperby Therapeutics Ltd	Combination
GB201620095D0 (en)	2016-11-28	2017-01-11	Terali Innov Sas And Univ De Strasbourg And Inserm (Inst Nat De La Sante Et De La Rech Medicale) And	Novel use
GB201709193D0 (en)	2017-06-09	2017-07-26	Helperby Therapeutics Ltd	Combination
WO2019141957A1 (en)	2018-01-19	2019-07-25	Cado Biotechnology Ivs	N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof
CA3099903A1 (en)	2018-05-11	2019-11-14	Forte Subsidiary, Inc.	Compositions for the treatment of skin conditions
WO2020081109A1 (en) *	2018-10-17	2020-04-23	Glenmark Pharmaceuticals Inc., Usa	Mupirocin cream in pump device
IL271778A (en)	2019-12-31	2021-06-30	Ichilov Tech Ltd	Methods for treating atopic dermatitis
WO2021203136A1 (en) *	2020-03-31	2021-10-07	Chemistryrx	Methods for treating hyperpigmentation and compositions for same
US20240180986A1 (en)	2021-03-30	2024-06-06	Dupont Nutrition Biosciences Aps	Compositions and methods for treating and preventing gastrointestinal inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3758686A (en) *	1971-12-07	1973-09-11	American Cyanamid Co	Method of using steroid acetonides
US3934013A (en) *	1975-02-21	1976-01-20	Syntex (U.S.A.) Inc.	Pharmaceutical composition
NZ200918A (en) *	1981-07-02	1985-07-31	Gist Brocades Nv	Stable fatty oil-in-water emulsion cream for topical application
GB8530796D0 (en) *	1985-12-13	1986-01-22	Beecham Group Plc	Pharmaceutical composition
IE59628B1 (en) *	1986-06-26	1994-03-09	Beecham Group Plc	Treatment of fungal infections
US4847068A (en) *	1987-08-06	1989-07-11	Johnson & Johnson Consumer Products, Inc.	Skin care compositions

1994
- 1994-10-20 WO PCT/US1994/012026 patent/WO1995010999A1/en active IP Right Grant
- 1994-10-20 CZ CZ19961120A patent/CZ292223B6/cs not_active IP Right Cessation
- 1994-10-20 HU HU9601030A patent/HU221853B1/hu active IP Right Grant
- 1994-10-20 AP APAP/P/1996/000798A patent/AP608A/en active
- 1994-10-20 EP EP94931943A patent/EP0727979B1/en not_active Expired - Lifetime
- 1994-10-20 SK SK495-96A patent/SK280222B6/sk not_active IP Right Cessation
- 1994-10-20 JP JP7512208A patent/JPH09506865A/ja active Pending
- 1994-10-20 ES ES94931943T patent/ES2157996T3/es not_active Expired - Lifetime
- 1994-10-20 DK DK94931943T patent/DK0727979T3/da active
- 1994-10-20 RO RO96-00817A patent/RO112987B1/ro unknown
- 1994-10-20 NZ NZ275282A patent/NZ275282A/en not_active IP Right Cessation
- 1994-10-20 CN CN94194238A patent/CN1102410C/zh not_active Expired - Lifetime
- 1994-10-20 AU AU80847/94A patent/AU692486B2/en not_active Expired
- 1994-10-20 KR KR1019960702041A patent/KR100374462B1/ko not_active IP Right Cessation
- 1994-10-20 PL PL94314038A patent/PL177592B1/pl unknown
- 1994-10-20 PT PT94931943T patent/PT727979E/pt unknown
- 1994-10-20 BR BR9407840A patent/BR9407840A/pt not_active Application Discontinuation
- 1994-10-20 UA UA96041570A patent/UA39896C2/uk unknown
- 1994-10-20 CA CA002174658A patent/CA2174658C/en not_active Expired - Lifetime
- 1994-10-20 AT AT94931943T patent/ATE202467T1/de active
- 1994-10-20 DE DE69427589T patent/DE69427589T2/de not_active Expired - Lifetime
1996
- 1996-04-12 BG BG100501A patent/BG62912B1/bg unknown
- 1996-04-19 FI FI961720A patent/FI116931B/fi not_active IP Right Cessation
- 1996-04-19 NO NO19961588A patent/NO313446B1/no not_active IP Right Cessation
- 1996-04-22 OA OA60817A patent/OA10361A/en unknown
1997
- 1997-07-25 US US08/903,255 patent/US6025389A/en not_active Expired - Lifetime
1998
- 1998-12-16 HK HK98113614A patent/HK1012284A1/xx not_active IP Right Cessation
2001
- 2001-09-11 GR GR20010401448T patent/GR3036591T3/el unknown

Also Published As

Publication number	Publication date
CN1102410C (zh)	2003-03-05
FI961720A0 (fi)	1996-04-19
CN1135715A (zh)	1996-11-13
NZ275282A (en)	1996-10-28
BR9407840A (pt)	1997-05-13
AU692486B2 (en)	1998-06-11
EP0727979A1 (en)	1996-08-28
HK1012284A1 (en)	1999-07-30
OA10361A (en)	2001-11-21
NO961588D0 (no)	1996-04-19
HU221853B1 (hu)	2003-02-28
ATE202467T1 (de)	2001-07-15
KR100374462B1 (ko)	2003-06-09
WO1995010999A1 (en)	1995-04-27
AU8084794A (en)	1995-05-08
CZ292223B6 (cs)	2003-08-13
CA2174658A1 (en)	1995-04-27
NO961588L (no)	1996-04-19
RO112987B1 (ro)	1998-03-30
CA2174658C (en)	2000-12-19
SK49596A3 (en)	1997-02-05
US6025389A (en)	2000-02-15
FI116931B (fi)	2006-04-13
AP9600798A0 (en)	1996-04-30
PL314038A1 (en)	1996-08-05
EP0727979B1 (en)	2001-06-27
PT727979E (pt)	2001-11-30
HU9601030D0 (en)	1996-06-28
JPH09506865A (ja)	1997-07-08
SK280222B6 (sk)	1999-10-08
NO313446B1 (no)	2002-10-07
PL177592B1 (pl)	1999-12-31
EP0727979A4 (en)	1996-11-27
FI961720A (fi)	1996-04-19
HUT74510A (en)	1997-01-28
UA39896C2 (uk)	2001-07-16
BG100501A (bg)	1996-12-31
ES2157996T3 (es)	2001-09-01
CZ112096A3 (en)	1996-07-17
DE69427589T2 (de)	2002-04-25
DK0727979T3 (da)	2001-10-01
GR3036591T3 (en)	2001-12-31
DE69427589D1 (de)	2001-08-02
AP608A (en)	1997-08-28

Publication	Publication Date	Title
BG62912B1 (bg)	2000-11-30	Фармацевтичен или ветеринарен състав, съдържащ мупироцин или негова сол
SK11993A3 (en)	1993-07-07	External preparation containing cyclosporin
CZ285679B6 (cs)	1999-10-13	Farmaceutický a kosmetický prostředek k místnímu nanášení na pokožku a způsob jeho přípravy
JPS6321648B2 (fi)	1988-05-09
US5538989A (en)	1996-07-23	Fenbendazole formulations
AU2001276567B2 (en)	2006-02-16	Antifungal ketoconazole composition for topical use
EP0445540B1 (en)	1995-04-19	Antimycotic external imidazole preparations
IL96903A (en)	1995-03-15	Topical pharmaceutical compositions comprising 1 alpha, 25-dihydroxychole-calciferol.
AU2001276567A1 (en)	2002-05-30	Antifungal ketoconazole composition for topical use
RU2148998C1 (ru)	2000-05-20	Фармацевтическая или ветеринарная композиция (варианты) и способ получения композиции
US20230330113A1 (en)	2023-10-19	Topical composition
EP0056681A2 (en)	1982-07-28	Levonantradol and N-methyllevonantradol formulations
KR101829049B1 (ko)	2018-02-26	비타민 d 유사체와 코르티코스테로이드를 포함하는 개선된 안정성을 갖는 약학 조성물
CZ269293A3 (en)	1994-07-13	Medicinal ointment without skin irritating effect and process for preparing thereof